Arriva Pharmaceuticals, Inc.: Series ? $6M

Posted in Q - 1Q08, R - WEST, X - Inflammation, X - Respiratory

Arriva Pharmaceuticals (Alameda, CA) a development stage biotechnology company focused anti-inflammatory therapies for treating respiratory diseases closed a $6M financing. Participants included Nordic Biotech and MPM Capital.

Cianna Medical, Inc.: Series A $9M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Oncology

Cianna Medica (Aliso Viejo, CA) a brachytherapy medical device company focused on women’s health and dedicated to the innovative treatment of early-stage breast cancer closed a $9M Series A financing. Participants include BioLucent, Fog City Fund and Windamere Venture Partners.

Obalon Therapeutics, Inc.: Series A $7.7M

Posted in I - Series A, Q - 1Q08, R - WEST, XX - Stealth Mode

Obalon Therapeutics (San Diego, CA) a stealth mode drug startup closed on a $4.7M tranche of a $7.7M Series A financing. Participants include Domain Associates, Okapi Ventures and Phagia Technology Inc.

Accumetrics, Inc.: Series D $65M

Posted in I - Series D, Q - 1Q08, R - WEST, X - Diagnostic

Accumetrics (San Diego, CA) develops diagnostic tests for measurement of anti-platelet drug response closed a $28.8M Series D financing, Participants include Arnerich Massena & Associates, BBT Fund, Essex Woodland Health Ventures, RiverVest, PTV Sciences, KB Partners and Kaiser Permanente Ventures.

Ocera Therapeutics, Inc. Series C $35.5M

Posted in I - Series C, Q - 1Q08, R - WEST, X - GI

Ocera Therapeutics (San Diego, CA) a clinical stage company focused on gastrointestinal and liver diseases closed a $35.5M Series C financing. Participants include Montagu Newhall Associates, InterWest Partners, AgeChem Venture Fund, Cross Creek Capital, FinTech, CDIB BioScience, Domain Associates, Sofinnova Ventures and Thomas, McNerney & Partners.

Moksha8, Inc.: Series B $15M

Posted in I - Series B, Q - 1Q08, R - WEST, X - Therapeutic Platform

Moksha8 (San Francisco, CA) a diversified commercialization stage company focused on delivery of products to emerging markets closed a combo $15M Series B financing and Series A (see below). Participants include TPG Biotech, Votorantim and Lit Tele.

Moksha8, Inc.: Series A $24M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Therapeutic Platform

Moksha8 (San Francisco, CA) a diversified commercialization stage company focused on delivery of products to emerging markets closed a combo $24M Series A financing and Series B (see above). Participants include TPG Biotech.

PEAK Surgical, Inc.: Series C $21M

Posted in I - Series C, Q - 1Q08, R - WEST, X - Device (Electrosurgery)

PEAK Surgical (Palo Alto, CA) an early-stage medical device company focused on pulsed plasma electrosurgery for cutting, coagulation and tissue welding closed a $21M Series C financing. Participants include Signet Healthcare Partners, Lehman Brothers and Venrock Associates.

Traversa Therapeutics, Inc.: Series A $2M

Posted in I - Series A, Q - 1Q08, R - WEST, X - RNAi

Traversa Therapeutics (La Jolla, CA) a discovery and development stage focused on RNAi delivery closed a $2M Series A financing. Participants include San Diego Tech Coast Angels, Mesa Verde Venture Partners and Morningside Group.

Sonexa Therapeutics, Inc.: Series A $30M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Alzheimer's

Sonexa Therapeutics (San Diego, CA) a development stage company focused Alzheimer’s closed a $30M Series A financing. Participants include Domain Associates, Scale Venture Partners, Alta Partners, AgeChem Venture Fund and MC Life Science Ventures.

« Previous Entries

to top of page...